AU2002238405A1 - Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases
- Google Patents
Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002238405A
Inventor
Hans Ole Svendsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mb Pharmos AS
Original Assignee
Mb Pharmos AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mb Pharmos ASfiledCriticalMb Pharmos AS
Publication of AU2002238405A1publicationCriticalpatent/AU2002238405A1/en
AU2002238405A2001-03-152002-03-15Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases
AbandonedAU2002238405A1
(en)
Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
Benzothiazole - and benzoxazole - 4,7 - dione derivatives, uses thereof for the preparation of a medicament, medicaments containing them and pharmaceutical compositions containing them
Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
Method for determining the therapeutic efficacy of a medicament against parkinson's disease and/or parkinson syndrome using anfri/fri mouse as a model